Genprex GNPX
NASDAQ GNPX
$3.43 -0.11 (-3.11%)
At close: Sep 9, 2026 · 4:00 PM EDT

Genprex (GNPX) EPS (Basic) (2016 - 2025)

Genprex (GNPX) posted EPS (Basic) of -$0.96 for Q1 2025, up 95.95% on a QoQ basis from -$23.78 in Q4 2024, and up 98.81% year-over-year from -$0.48 in Q1 2024.

Analysis

Genprex (GNPX) EPS (Basic) (2016 - 2025) Analysis & Trends

Genprex has reported EPS (Basic) for 10 years, with the latest figure at -$0.96 in Q1 2025.

  • On a quarterly basis, EPS (Basic) rose 98.81% year-over-year to -$0.96 in Q1 2025; TTM through Mar 2025 was -$22.78, a 93.93% increase from a year earlier, with the FY2024 full-year figure at -$117.46, up 76.34% from the prior year.
  • EPS (Basic) was -$0.96 for Q1 2025 at Genprex, up from -$23.78 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.96 in Q1 2025, with the low at -$95.36 in Q4 2023.
  • Average EPS (Basic) over 5 years is -$19.11, with a median of -$2.99 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: EPS (Basic) tumbled 3086.04% in 2023, then surged 98.81% in 2025.
  • Over 5 years, EPS (Basic) stood at -$3.15 in 2021, then increased by 5.09% to -$2.99 in 2022, then sank by 3086.04% to -$95.36 in 2023, then jumped by 75.06% to -$23.78 in 2024, then jumped by 95.95% to -$0.96 in 2025.
  • The last three EPS (Basic) figures came in at -$0.96 (Q1 2025), -$23.78 (Q4 2024), and -$27.13 (Q3 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.85
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -0.94
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -0.11
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 0.42
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn -1.22
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -1.18
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 0.06
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -0.05
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 0.04
10 Genprex 1.61 Mn -13.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -0.96
Dec 31, 2024 -23.78
Sep 30, 2024 -27.13
Jun 30, 2024 -66.10
Mar 31, 2024 -81.15
Dec 31, 2023 -95.36
Sep 30, 2023 -2.94
Jun 30, 2023 -3.38
Mar 31, 2023 -4.09
Dec 31, 2022 -2.99
Sep 30, 2022 -2.82
Jun 30, 2022 -2.65
Mar 31, 2022 -2.44
Dec 31, 2021 -3.15
Sep 30, 2021 -1.59
Jun 30, 2021 -1.85
Mar 31, 2021 -2.56
Dec 31, 2020 -3.24
Sep 30, 2020 -1.56
Jun 30, 2020 -2.72